5 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 5 Phase 4, 3 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Not applicable | 2 | Completed 2 |
Follow Dopamine Agonists: new trials by email Literature Review of Dopamine Agonists trials Research Report on Dopamine Agonists
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Carbergoline for Antipsychotic Induced Hyperprolactinemia. Cabergoline (Dopamine Agonist), Placebo - Scizophrenia | Phase 4 | Not yet recruiting | Zealand University Hospital | 146 | 2026-05-01 | 2026-02-04 |
| Cabergoline for Episodic Migraine Cabergoline 0.5 MG, Placebo, Cabergoline 1 MG - Migraine | Phase 2 | Recruiting | Aarhus University Hospital | 150 | 2025-11-12 | 2025-11-18 |
| Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment Cabergoline (Dopamine Agonist) - Prolactinoma | Phase 4 | Recruiting | University Hospital, Basel, Switzerland | 60 | 2025-09-16 | 2025-09-23 |
| Exercise Training Versus Ropinirole in Treating Restless Legs Syndrome Among Hemodialysis Patients Dopamine Agonist (Ropinirole), Excercise training - Hemodialysis, Restless Legs Syndrome | Not applicable | Completed | Lahore General Hospital | 84 | 2022-01-02 | 2024-06-21 |
| Pramipexole for Restless Leg Syndrome in Peritoneal Dialysis Patients Pramipexole, placebo - Restless Legs Syndrome | Phase 4 | Terminated | Dong Jie | 21 | 2019-07-01 | 2021-12-09 |
| PRolaCT - Three Prolactinoma RCTs Endoscopic trans-sphenoidal adenoma resection, Dopamine Agonists - Prolactinoma, Prolactin-Producing Pituitary Tumor | Phase 4 | Unknown | Leiden University Medical Center | 880 | 2019-06-21 | 2020-07-20 |
| Evaluation of the Nonmotor Symptomatology of Parkinsonian Patients Treated With Two Strategies Related to Apomorphine Pump Therapy in French Hospitals Apomorphine, Dopaminergic Agonist + Apomorphine - Parkinson Disease | Not applicable | Completed | Rennes University Hospital | 43 | 2019-05-15 | 2023-11-27 |
| P2X7 Receptor, Inflammation and Neurodegenerative Diseases Memantine, Dopamine receptor-agonists - Neuro-Degenerative Disease | Completed | University of Pisa | 50 | 2017-02-20 | 2019-08-13 | |
| L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease L-dopa, Dopamine Agonists (pramipexole, ropirinole) - Parkinson's Disease | Phase 2 | Unknown | University of Toronto | 40 | 2015-01-01 | 2015-01-27 |
| Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa Levodopa/Carbidopa(200mg/50mg), Dopaminergic Agonists - Impulse Control Disorder | Phase 4 | Completed | Sandoz | 150 | 2012-11-01 | 2021-03-10 |
| Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS) Dopamine Agonist and Exercise - Restless Legs Syndrome, End Stage Renal Disease | Phase 2 | Completed | University of Thessaly | 46 | 2006-09-01 | 2010-07-05 |
Parkinson Disease (3) · Restless Legs Syndrome (3) · Prolactinoma (2) · Alzheimer Disease (1) · Diabetes Complications (1) · Disruptive, Impulse Control, and Conduct Disorders (1) · Hyperprolactinemia (1) · Kidney Failure, Chronic (1) · Migraine Disorders (1) · Motor Activity (1) · Prolactin Deficiency, Isolated (1) · Renal Insufficiency, Chronic (1) · Sleep Wake Disorders (1)
Aarhus University Hospital (1) · Dong Jie (1) · Lahore General Hospital (1) · Leiden University Medical Center (1) · Rennes University Hospital (1) · Sandoz (1) · University Hospital, Basel, Switzerland (1) · University of Pisa (1) · University of Thessaly (1) · University of Toronto (1) · Zealand University Hospital (1)
Denmark (2) · Canada (1) · China (1) · France (1) · Greece (1) · Italy (1) · Netherlands (1) · Pakistan (1) · South Korea (1) · Switzerland (1)
Alfonso Fasano, MD, PhD (1) · Anna Solini, MD, PhD (1) · Cihan Atila, Dr. (1) · Giorgos K Sakkas, PhD (1) · Ioannis Stefanidis, MD PhD (1) · Jesper Krogh (1) · Jie Dong (1) · Jinwhan Cho, MD (1) · Muhammad Irfan Jamil, MBBS, FCPS (1) · Nienke R Biermasz, MD, prof. (1) · Wouter R van Furth, MD, PhD (1)
PMID 23929523, PMID 24024727, PMID 26262586, PMID 30361296, PMID 32075834, PMID 34563236, PMID 35018639
2025 (2)